A prescription anticoagulant containing rivaroxaban 20 mg. It directly inhibits factor Xa to reduce clot formation and is prescribed for selected prevention or treatment indications.

Expected benefit:
Reduces blood clot formation when prescribed for an appropriate prevention or treatment indication; the exact benefit depends on the patient’s diagnosis.

Key information:
• 28 film-coated tablets.
• Rivaroxaban 20 mg per tablet.
• The prescribed indication, dose schedule and duration must be individualized.

Ingredients / composition:
Active ingredient: rivaroxaban 20 mg per film-coated tablet. The local product may contain lactose and other tablet-core/film-coat excipients; consult the current Zarlan leaflet or carton for the complete excipient list.

Recommended use:
Take exactly as prescribed. The 20 mg tablet must be taken with food and swallowed with water, preferably at the same time daily. Never stop or change anticoagulant treatment without the prescriber’s advice.

Warnings and disclaimer:
Serious bleeding is the main risk. Obtain urgent help for uncontrolled bleeding, black stools, blood in urine/vomit, coughing blood, severe headache, unusual weakness or head injury. Inform healthcare professionals before surgery or dental work. Other anticoagulants, antiplatelets, NSAIDs and strong CYP3A4/P-gp modifiers can interact. Kidney/liver disease, pregnancy and breastfeeding require specific medical assessment. Read the local leaflet.